ALL NEWS


23  July 2020

New Delhi: The coronavirus vaccine developed at the Oxford University will be in India by November and will ultimately cost Rs 1,000, said the Indian firm partnering the UK researchers.

The manufacturing of the Covishield vaccine had started parallelly with the clinical trials, the first ...

22  July 2020

Nearly one in four residents in India's capital, Delhi, has been exposed to coronavirus infection, antibody tests on a random sample of people suggest.

The government survey said 23.48% of the 21,387 people whose blood samples were tested had Covid-19 antibodies.

It suggests th ...

22  July 2020

On Monday, British vaccinologist Sarah Gilbert and her team at Oxford University leapfrogged towards the finish line, leaving other contenders behind, in the race to find the vaccine for the novel coronavirus.

The early findings of Gilbert and her team's research have shown promising resu ...

21  July 2020

As news of the Oxford vaccine working positively started circulating, Indians started lining up on Twitter to be 'next in line' to get it on a mass scale - by celebrating it with memes.

Oxford University’s Phase-1 and Phase-2 trials on their Covid-19 vaccine showed that there was no maj ...

20  July 2020

At least seven Indian pharma companies are working to develop a vaccine against coronavirus as they join global efforts to find a preventive to check the spread of the deadly virus that has already infected more than 14 million globally.

Bharat Biotech, Serum Institute, Zydus Cadila, Pana ...

20  July 2020

The UK government has signed deals for 90 million doses of promising coronavirus vaccines that are being developed.

The vaccines are being researched by an alliance between the pharmaceutical companies BioNtech and Pfizer as well as the firm Valneva.

The new de ...

17  July 2020

The United Nations is making an appeal for $10.3 billion (£8.2 billion) to help fight the coronavirus pandemic, its largest ever fundraising call.

The UN says up to 265 million people could face starvation by the end of the year because of the impact of Covid-19. The money will be for u ...

17  July 2020

Russian spies are targeting organisations trying to develop a coronavirus vaccine in the UK, US and Canada, security services have warned.

The UK's National Cyber Security Centre (NCSC) said the hackers "almost certainly" operated as "part of Russian intelligence services".

It di ...

14  July 2020

Bengaluru-based Biocon Limited’s Itolizumab drug that was granted emergency use approval for treating Covid-19 patients was cleared on the basis of a randomised clinical trial of just 30 patients across four centres, the company revealed on Monday.

Itolizumab is an existing drug used to ...

13  July 2020

Glenmark has also completed the phase 3 clinical trial with Favipiravir (FabiFlu) in mild to moderate COVID-19 patients in India. The trial results will be available shortly, the company said. Drug firm Glenmark Pharmaceuticals on Monday said it has cut price of its antiviral drug Favipiravir, unde ...

13  July 2020

Moscow: The clinical trials of the world's first coronavirus vaccine on volunteers has been successfully completed at Sechenov First Moscow State Medical University, Sputnik news agency reported quoting an official.

The Sechenov First Moscow State Medical University b ...

07  July 2020

Bengaluru: Drugmaker Mylan NV said on Monday it would launch its generic version of Gilead Sciences Inc's COVID-19 treatment remdesivir in India this month at 4,800 rupees ($64.31) per 100 mg vial, as infections surge in the world's third worst-hit country.

The Drug Contr ...

07  July 2020

New Delhi: More than 1,100 people are expected to be enrolled in the first two phases of human clinical trials for COVAXIN - India's first COVID-19 vaccine candidate, an application by developers Bharat Biotech said Friday.

Phase I clinical trials are scheduled to start ne ...

06  July 2020

The head of the US drugs regulator has cast doubt on President Donald Trump's prediction that a Covid-19 vaccine will be ready this year. "I can't predict when a vaccine will be available," US Food and Drug Administration (FDA) Commissioner, Dr Stephen Hahn, said on Sunday. Dr Hahn said vaccine de ...

06  July 2020

Hundreds of scientists say there is evidence that novel coronavirus in smaller particles in the air can infect people and are calling for the World Health Organization (WHO) to revise recommendations, the New York Times reported on Saturday.

The WHO has said the coronavirus disease spread ...

03  July 2020

The Indian Council of Medical Research (ICMR) has set an ambitious launch date of August 15 for the public use of the Coronavirus vaccine being developed in partnership with Hyderabad-based Bharat Biotech.

“It is envisaged to launch the vaccine for public health use latest by 15th Augus ...

03  July 2020

New Delhi: The Drug Controller General of India has approved pharmaceutical firm Zydus Cadila to start Phase I and Phase II human clinical trials of its COVID-19 vaccine. This is the second vaccine after Hyderabad-based Bharat Biotech's COVAXIN to get the approval.

Drug manufacturers arou ...

01  July 2020

South Korea has started distributing stocks of remdesivir, a drug being used to treat Covid-19.   

The supply has been donated by Gilead Sciences and discussions are under way to purchase supplies in August, the Korea Centers for Disease Control said.

"Patients who a ...

01  July 2020

A whopping majority of infections and deaths in India happened in June - more than 400,000 cases and nearly 12,000 fatalities were reported last month, according to the Times of India newspaper.

To put that into perspective, India currently has 568,092 confirmed cases and 17,400 deaths, a ...

01  July 2020

US President Donald Trump's administration has secured almost all the world's upcoming supply of the drug remdesivir. The drug, produced by the firm Gilead Sciences, is the first approved by authorities in the US to be used to treat Covid-19.

It has been shown to help people recover faste ...